MN HF348

Health plans must limit cost-sharing for prescription drugs treating chronic disease to no more than $25 per one-month supply for each drug, regardless of medication amount or type.

Health plans must limit cost-sharing for related medical supplies (syringes, insulin pens, insulin pumps, test strips, glucometers, continuous glucose monitors, epinephrine auto-injectors, asthma inhalers) to no more than $50 per month total, with no increase based on number of chronic diseases.

Coverage under these limits is not subject to any deductible, with exception that limits apply after deductible is met if application before meeting deductible would result in health savings account or catastrophic health plan ineligibility.

Chronic disease is defined as diabetes, asthma, and allergies requiring epinephrine auto-injectors.

Requirements apply to medical assistance benefit plans and Basic Health Program plans, effective January 1, 2024, for health plans offered, issued, or renewed on or after that date.